Applications are now open for Legend Biotech’s inaugural ELITE Program (Emerging Leadership & Innovation in Cell Therapy Excellence).

The annual grant initiative is designed to recognize and support early-career healthcare professionals advancing novel cell therapy approaches for the treatment of multiple myeloma.

Through the ELITE Program, we’re investing in the next generation of innovators and the ideas that can help advance research, education, and care for patients living with multiple myeloma.

Applications are open through November 20, 2026. Learn more and apply: https://bit.ly/4wnt47v